M42 and Great Ormond Street Hospital for Children join hands
M42, a global tech-enabled health powerhouse, has partnered with one of the world’s leading children’s hospitals, Great Ormond Street Hospital for Children (GOSH), in London, part of the National Health Service (NHS) in the United Kingdom. Together, the partners will introduce an innovative education initiative to enhance pediatric critical and complex care in the region, with an initial focus on M42’s Danat Al Emarat Hospital for Women and Children, a pioneer in paediatric health in the UAE.
GOSH, globally acclaimed for its expertise in treating children with rare and complex medical conditions, compliments M42’s mission to impactfully transform global health. This multifaceted collaboration will support children with complex medical conditions in the initial phase through education programs, with a vision to extend the partnerships to include genomics and research. Together, they aim to advance genomics, and cell and gene therapy.
Ashish Koshy, Group Chief Operating Officer of M42, said: “Through collaborations such as this, M42 is impactfully disrupting global health. We see our partnership with Great Ormond Street Hospital as an opportunity to take pediatric health to a new level in the region and reset best practices globally. By combining GOSH’s world-class solutions with M42’s innovative health solutions, we are positioning ourselves to really make a difference. Further strengthening M42’s clinical operations, and reshaping excellence for children’s health.”
Christopher Rockenbach, Director of International and Commercial at Great Ormond Street Hospital for Children, said: “We are proud of our long-standing relationship with the UAE and excited to be strengthening our commitment to the region with such an esteemed partner as M42. We look forward to contributing to improving children’s health through this collaboration.”
Lynn Shields, Director of Education at Great Ormond Street Hospital Learning Academy, said: “Education underpins everything we do at GOSH. In collaborating with M42, we have a unique opportunity to significantly impact pediatric healthcare by sharing our knowledge and expertise and delivering outstanding, targeted educational programs.”
Through this partnership, M42’s Danat Al Emarat Hospital for Women and Children, will be empowered to cater to specific health conditions with unprecedented precision and excellence, ensuring an even higher level of care for its young patients. The collaboration will streamline patient care, through the establishment of a robust joint Multidisciplinary Team (MDT) approach between Danat Al Emarat and GOSH, a second opinion framework and a visiting consultant program.
With Level 3 Neonatal Intensive Care Unit (NICU) and Pediatric Intensive Care Unit (PICU) facilities at Danat Al Emarat Hospital, the innovative partnership with GOSH will enhance the quality of pediatric and neonatal critical care.
Omar Al Naqbi, Acting Executive Director at Danat Al Emarat Hospital for Women and Children, said: “We’re thrilled to be exploring such an exciting collaboration with GOSH. GOSH is recognized all over the world for the incredible standards of care it delivers. This collaboration is a testament to our commitment to the children of the UAE, ensuring they have access to the best care possible. It also highlights our dedication to ensuring our clinical teams continue to develop professionally and provide the highest level and standards of clinical care.”
There will be a strong focus on upskilling Danat Al Emarat Hospital’s clinical teams, especially in the PICU and NICU, which require some of the most complex skills. GOSH is set to provide expert clinical training programs, including participation in GOSH Grand Rounding to facilitate shared learning and continued education.
GOSH has a long-standing relationship with the UAE and is home to the Zayed Centre for Research into Rare Disease in Children, a state-of-the-art center that brings together pioneering research and world-leading clinical care under one roof. The center opened in 2019, thanks to a transformational gift from Her Highness Sheikha Fatima bint Mubarak, wife of the late Sheikh Zayed bin Sultan Al Nahyan, the founder of the UAE.
This collaboration will also explore numerous research and innovation projects including – advancing genomics, and pioneering cell and gene therapy approaches which aligns with M42’s role as the facilitator of the Emirati Genome Program in the UAE. Other areas of exploration may include machine learning and AI, such M42’s generative AI language model, Med42.
The agreement ceremony which took place at M42 stand during Arab Health, was signed by Ashish Koshy, Group Chief Operating Officer of M42, and Christopher Rockenbach, Managing Director of International and Commercial, Great Ormond Street Hospital for Children NHS Foundation Trust.
Last Updated on 1 month by Middle East News 247